Page last updated: 2024-08-24

cilazapril, anhydrous and Chronic Disease

cilazapril, anhydrous has been researched along with Chronic Disease in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's8 (61.54)18.2507
2000's4 (30.77)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knap, N; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M1
Aleksandrowicz, E; Larczyński, W; Lysiak-Szydlowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L1
Chernov, VI; Kapishchenko, TD; Karpov, RS; Pavliukova, EN1
Clozel, JP; Clozel, M; Hess, P; Löffler, BM; Maire, JP; Teerlink, JR1
Bayar, MA; Erbengi, T; Iplikcioglu, AC; Sav, A1
Brera, V; Di Michele, R; Lucini, D; Malliani, A; Pagani, M; Pizzinelli, P; Sommariva, D1
Asakuma, S; Fujiwara, M; Iwasaki, T; Nakamura, K; Nakamura, T1
Erbel, R; Meyer, J; Mohr-Kahaly, S; Weyer, C1
Mulder, P; Richard, V; Thuillez, C1
Kageyama, J; Kataoka, H; Makino, H; Ogura, T; Otsuka, F; Sato, M; Yamauchi, T1
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Tokuyama, H; Wakino, S1
Clozel, JP1

Trials

4 trial(s) available for cilazapril, anhydrous and Chronic Disease

ArticleYear
Spironolactone attenuates oxidative stress in patients with chronic kidney disease.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Creatinine; Cross-Over Studies; Dinoprost; Diuretics; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Spironolactone; Telmisartan

2008
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 52, Issue:3

    Topics: Acetylglucosaminidase; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Chronic Disease; Cilazapril; Collagen Type III; Cross-Over Studies; Disease Progression; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Male; Mineralocorticoid Receptor Antagonists; Potassium; Proteinuria; Renin-Angiotensin System; Spironolactone; Telmisartan

2008
[The effect of cilazapril on left ventricular function and myocardial perfusion in patients with essential hypertension (hypertensive disease) stage II].
    Terapevticheskii arkhiv, 1995, Volume: 67, Issue:9

    Topics: Angina Pectoris; Antihypertensive Agents; Chronic Disease; Cilazapril; Coronary Circulation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Time Factors; Ventricular Function, Left

1995
Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
    Cardiology, 1995, Volume: 86 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Chronic Disease; Cilazapril; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged

1995

Other Studies

9 other study(ies) available for cilazapril, anhydrous and Chronic Disease

ArticleYear
Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
    Circulation, 1994, Volume: 90, Issue:5

    Topics: Animals; Blood Pressure; Bosentan; Chronic Disease; Cilazapril; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Male; Rats; Rats, Wistar; Sulfonamides

1994
Angiotensin-converting enzyme inhibitor cilazapril prevents chronic morphologic vasospasm in rat.
    Surgical neurology, 1994, Volume: 41, Issue:4

    Topics: Animals; Chronic Disease; Cilazapril; Disease Models, Animal; Femoral Artery; Ischemic Attack, Transient; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction

1994
[The effects of chronic cilazapril treatment on sympathetic vasomotor tonus: a spectral analysis study of pressure variability].
    Cardiologia (Rome, Italy), 1993, Volume: 38, Issue:3

    Topics: Blood Pressure; Chronic Disease; Cilazapril; Drug Evaluation; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Muscle Tonus; Signal Processing, Computer-Assisted; Sympathetic Nervous System; Vasomotor System

1993
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Journal of cardiology, 1995, Volume: 26, Issue:5

    Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Chronic Disease; Cilazapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume

1995
[Follow-up of patients with chronic aortic valve insufficiency with ACE inhibitor therapy].
    Zeitschrift fur Kardiologie, 1997, Volume: 86, Issue:12

    Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Insufficiency; Cardiac Volume; Chronic Disease; Cilazapril; Echocardiography; Echocardiography, Doppler, Color; Female; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Function, Left

1997
Different effects of calcium antagonists in a rat model of heart failure.
    Cardiology, 1998, Volume: 89 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Calcium Channel Blockers; Catecholamines; Chronic Disease; Cilazapril; Heart Failure; Heart Ventricles; Hemodynamics; Male; Mibefradil; Myocardial Contraction; Random Allocation; Rats; Rats, Wistar; Renin; Survival Rate; Tetrahydronaphthalenes

1998
Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.
    Kidney & blood pressure research, 2000, Volume: 23, Issue:1

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Nucleus; Chronic Disease; Cilazapril; Desoxycorticosterone; Electrophoresis; Heart Rate; Hypertension; Kidney Glomerulus; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transcription Factor AP-1

2000
Differential regulation of elevated renal angiotensin II in chronic renal ischemia.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:1

    Topics: Angiotensin I; Angiotensin II; Animals; Chronic Disease; Chymases; Cilazapril; Dogs; Hemodynamics; Hypertension, Renal; Imidazoles; Ischemia; Kidney; Male; Oligopeptides; Olmesartan Medoxomil; Peptidyl-Dipeptidase A; Renal Circulation; Renin-Angiotensin System; Serine Endopeptidases; Tetrazoles

2002
Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.
    British journal of clinical pharmacology, 1989, Volume: 27 Suppl 2

    Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Cilazapril; Heart Failure; Hemodynamics; Myocardial Infarction; Myocardium; Pyridazines; Rats; Rats, Inbred Strains; Vascular Resistance

1989